

> Primary headache syndromes (International Headache Society Classification)


# HEADACHE

### Primary headache syndromes (International Headache Society Classification)

• **Tension-type:** bilateral, pressure-like pain of mild–mod intensity, not throbbing or aggra-vated by physical activity. A/w photophobia or phonophobia, not N/V. Freq a/w myofascial sensitivity in neck/head. Triggers: stress, sleep deprivation, dehydration, hunger. Episodic HA Rx: NSAIDs, acetaminophen (risk of med overuse HA); chronic HA Rx: TCAs.

• **Cluster HA** and other trigeminal autonomic cephalalgias (TACs) (_Continuum_ 2018;24:1137)

Characterized by unilateral headache a/w ipsilateral autonomic sx (rhinorrhea, red/tearing eye, miosis, ptosis, lid edema, sweating), subtypes differentiated by timing.

_Cluster:_ ♂ > ♀, unilateral pain with autonomic sx & restlessness; attacks 15 min–3 h, up to 8/d (circadian). Ppx: CCB (verapamil). Rx: high-flow O2 (12–15 L/min), sumatriptan.

_Paroxysmal hemicrania:_ similar to cluster, but ♀ > ♂, attacks 2–30 min. Rx: indomethacin.

_Hemicrania continua:_ ♀ > ♂, ice pick–like pain lasting >3 mo. Rx: indomethacin.

_Short-lasting unilateral neuralgiform HA_ (SUNA/SUNCT)_:_ ♂ > ♀, excruciating, stabbing, electrical pain, 5 sec–4 min, up to 200×/d. Rx: lamotrigine, gabapentin, topiramate.

• **Migraine:** _see below_

Secondary causes of headaches

• Traumatic: post-concussion, SAH, SDH, postcraniotomy

• ↑ ICP: mass (tumor, abscess, vascular malformations, ICH), hydrocephalus, idiopathic intracranial hypertension (pseudotumor cerebri), altitude-associated cerebral edema

• ↓ ICP: post-LP headache, CSF leak/dural tear, overshunting

• Vascular: stroke (esp. posterior circ), dissection, vasculitis (incl. temporal arteritis), reversible cerebral vasoconstriction syndrome (RCVS), ICH, venous sinus thrombosis

• Meningeal irritation: meningitis, SAH

• Extracranial: sinusitis, TMJ syndrome, glaucoma

• Systemic: hypoxia (OSA), hypercapnia, dialysis, HTN, cardiac cephalalgia, hypoglycemia, ↓ TSH, pheo, medication overuse (analgesics), withdrawal (caffeine, opioids, estrogen)

臨床evaluation (_JAMA_ 2006;296:1274 & 2013;310:1248)

• History: onset (sudden vs. gradual), quality, severity, location, duration, triggers, alleviating factors, positional component, hormonal triggers (menstruation), preceding trauma, associated sx (visual Δs, “floaters,” N/V, photophobia, focal neurologic sx), medications (analgesics), substance abuse (opioids, caffeine), personal/family hx of HA

• General and neurologic exam (including funduscopic exam, visual fields)

• **Warning signs (should prompt neuroimaging)**

_Explosive onset_ (vasc); “worst HA of my life” (SAH, RCVS); _meningismus_ (SAH, infxn)

_Positional:_ lying > standing (↑ ICP); _N/V_ (↑ ICP; migraines)

_Visual sx:_ diplopia, blurring, ↓ acuity (GCA, glaucoma, ↑ ICP); _eye pain_ (glaucoma, trigeminal autonomic cephalalgia, optic neuritis)

_異常 neuro exam_ (struct. lesion, poss. in migraine); ↓ _consciousness_ (± fever): infxn, ICH

_Age_ >_50 y; immunosuppression_ (CNS infections, PRES)

• Imaging: CT or MRI; consider CTA (beading in vasculitis/RCVS/vasospasm), CTV/MRV

• LP if ? SAH (✔ for xanthochromia), idiopathic intracranial HTN (✔opening press); image first!

MIGRAINE (_NEJM_ 2017;377:553)

定義 & 臨床表現 (_Lancet_ 2018;391:1315)

• **流行病學:** affects 15% of women and 6% of men; onset usually by 30 y

• **Migraine without aura** (most common): ≥5 attacks lasting 4–72 h with both (a) N/V _or_ photophobia & phonophobia, and (b) ≥2 of following: unilateral, pulsating, mod–severe intensity, or aggravated by routine activity

• **Migraine with aura:** ≥2 attacks with: (a) aura defined as ≥1 fully reversible sx: visual Δs (flickering spots, visual loss), sensory sx (paresthesias, numbness), speech disturbance; _and_ (b) unilateral progression of sx(s) over ≥5 but ≤60 min; _and_ (c) HA within 60 min of aura

• Aura may occur without HA (“acephalgic migraine”), must 排除 TIA/stroke (typically rapid onset)

• If motor weakness, consider **sporadic or familial hemiplegic migraine**: aura of reversible motor weakness (up to 24 h), a/w CACNA1A, ATP1A2, or SCN1A mutations

• Precipitants: stress, foods (cheese, chocolate, MSG), fatigue, EtOH, menses, exercise

治療

• Abortive Rx: 5-HT1 agonists (triptans) effective if given early in migraine attack; contraindicated if motor aura, CAD, prior stroke. Also consider acetaminophen, caffeine, NSAIDs (ketorolac), steroids, Mg, metoclopramide, prochlorperazine, valproate, dihydroergotamine (caution if CAD, recent triptan use). _Avoid butalbital, opioids._

• Prophylaxis: valproic acid, topiramate, β-blockers (propranolol first-line), TCAs, Mg, B2, botox, anti-CGRP & receptor mAbs (femanezumab, erenumab; _NEJM_ 2017;377:2113 & 2123)
